Delivery Order SPE2DB20D1109-SPE2DB23FP05A
- Not listed
- This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract is a delivery order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC...
- This federal contract award, valued at $2,252.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 22, 2025. It is not designated as a set-aside contract, indicating...
- This federal contract award, valued at $2,252.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract is a delivery order with a firm fixed price and an ultimate completion date of April 7, 2025. It is not designated as a set-aside contract, indicating open competition....
- This federal contract award, valued at $4,372.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 20, 2023. This award is not associated with a set-aside...
- This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of September 13, 2023 and is structured as a firm fixed-price delivery order. No set-aside designation was used for this award....
- This federal contract award, valued at $6,833.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used for diabetes management. This is a firm fixed-price delivery order contract with a completion date of September 19, 2023. The award was made through full and open competition, with no set-aside designations. Amerisourcebergen Drug...
- This federal contract award, valued at $2,545.14, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $2,104.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 mL pens, a medication used for the treatment of diabetes. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025....
- This federal contract award, valued at $1,161.12, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major...
- This federal contract award, valued at $3,245.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a pharmaceutical product used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2024. The contract was awarded on a full and open competition basis, with no set-aside designation....
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP05ADelivery Order
This federal contract award, valued at $1,362.44, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat type 2 diabetes. The contract, which has a completion date of May 2, 2023, is a delivery order and is priced on a firm fixed-price basis. This award is not associated with any set-aside requirements, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/1/23 |